DOCSLIB.ORG

Microrna Dysregulation Interplay with Childhood Abdominal Tumors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Microrna Dysregulation Interplay with Childhood Abdominal Tumors Cancer and Metastasis Reviews (2019) 38:783–811 https://doi.org/10.1007/s10555-019-09829-x MicroRNA dysregulation interplay with childhood abdominal tumors Karina Bezerra Salomão1 & Julia Alejandra Pezuk2 & Graziella Ribeiro de Souza1 & Pablo Chagas1 & Tiago Campos Pereira3 & Elvis Terci Valera1 & María Sol Brassesco3 Published online: 17 December 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Abdominal tumors (AT) in children account for approximately 17% of all pediatric solid tumor cases, and frequently exhibit embryonal histological features that differentiate them from adult cancers. Current molecular approaches have greatly improved the understanding of the distinctive pathology of each tumor type and enabled the characterization of novel tumor biomarkers. As seen in abdominal adult tumors, microRNAs (miRNAs) have been increasingly implicated in either the initiation or progression of childhood cancer. Moreover, besides predicting patient prognosis, they represent valuable diagnostic tools that may also assist the surveillance of tumor behavior and treatment response, as well as the identification of the primary metastatic sites. Thus, the present study was undertaken to compile up- to-date information regarding the role of dysregulated miRNAs in the most common histological variants of AT, including neuroblas- toma, nephroblastoma, hepatoblastoma, hepatocarcinoma, and adrenal tumors. Additionally, the clinical implications of dysregulated miRNAs as potential diagnostic tools or indicators of prognosis were evaluated. Keywords miRNA . Neuroblastoma . Nephroblastoma . Hepatoblastoma . Hepatocarcinoma . Adrenal tumors 1 MicroRNA biogenesis and function retaining the hairpin (pre-miRNA, ~ 70 nucleotides long), which is translocated by Exportin-5 to the cytoplasm, and then Fundamentally, all cellular programs are controlled by genes: processed by another endoribonuclease (Dicer) into the growth, senescence, division, metabolism, stemness, mobility, miRNA duplex. Once loaded into the RNA-induced silencing apoptosis, and more. In turn, gene expression is also tightly complex (RISC), one strand of the duplex is destroyed while regulated by different mechanisms, such as microRNAs the other directs RISC to messenger RNAs (mRNAs) with (miRNAs). miRNAs are a class of small, non-protein coding partial (or total) complementary sequences [2]. RISC then RNA molecules (approximately 22 nucleotides long) that me- interrupts the production of the protein by one of the different diate post-transcriptional gene silencing [1]. These short RNA ways: inhibition of translation (which is reversible), regulators are encoded by “miRNA genes,” which are tran- decapping, deadenylation, or cleavage [3]. MiRNAs often, scribed by RNA polymerase II as a primary miRNA (pri- but not exclusively, hybridize with complementary sites with- miRNA) containing a 5′ CAP, a 3′ poly-A tail, and an internal in the 3′ untranslated region (UTR) of targeted mRNAs. One hairpin-structured region. Pri-miRNA is then cleaved by the specific miRNA may target many different mRNAs, and nuclear endoribonuclease Drosha into the precursor miRNA thereby, one mRNA may also be controlled by many distinct miRNAs. The region comprising nucleotides 2 to 8 of the 5′ terminus of miRNAs is known as the “seed” sequence: a re- * María Sol Brassesco gion of total complementarity to the targeted mRNA that is [email protected] critical for miRNA pairing and function [3]. Sixty percent of all genes in the human genome display at 1 Ribeirão Preto Medical School, University of São Paulo, Av. Dr. least one conserved site for miRNA binding [4]. Consequently, Rudge Ramos, 1501 - Jardim Abc, São Bernardo do all biological processes are regulated by this class of molecules Campo, SP 09639-000, Brazil [5–9]. Due to their roles in several key events, dysregulation of 2 Anhanguera University of São Paulo, UNIAN/SP, Av. Dr. Rudge miRNAs has also been associated with diverse aspects of can- Ramos, 1501 - Jardim Abc, São Bernardo do Campo, SP 09639-000, Brazil cer biology [10]. Thus, in this review, we compile growing information on miRNAs’ dysregulation along with a summary 3 Biology Department, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Avenida Bandeirantes, 3900 of opportunities for their use as specific biomarkers in most - Vila Monte Alegre, Ribeirão Preto, SP 14040-900, Brazil prominent pediatric abdominal tumors. 784 Cancer Metastasis Rev (2019) 38:783–811 2 Abdominal tumors in children Moreover, due to their multi-target nature, miRNAs act si- multaneously on several signaling pathways, affecting process- Abdominal tumors (AT) in the pediatric population, in- es such as metabolism control, cell differentiation, and apopto- cluding renal tumors, sympathetic nervous system tumors, sis [19]. miRNAs that repress tumor suppressor genes and malignant liver tumors, and gonadal tumors, correspond thereby favor tumor growth are called oncogenes or to ~ 17% of all pediatric solid tumor cases [11]. oncomiRs and are generally upregulated in tumors. Clinically, these masses vary in their clinical signs and Conversely, miRNAs that negatively regulate the expression symptoms, depending on the causative physiopathology: of genes related to tumor growth are considered tumor suppres- they can be largely asymptomatic and uncovered during sors and are downregulated in tumors. Their downregulation routine clinical exam (as for nephroblastomas) or be ob- may result in mutations in genomic regions associated with served in the context of a systemic disease in a severely ill cancer or in fragile sites of the genome [20], as a result of patient. Many abdominal masses in children can develop epigenetic modifications [21, 22], or through altered function- in utero (i.e., congenital mesoblastic nephroma, teratomas, ing of elements from their biogenesis machinery such as Dicer, neuroblastoma, and mesenchymal hamartoma of the liver, Drosha, DGCR8, Argonaut, and Exportin-5 [23]. In this re- amongothers).Inthislifeperiod, other non-neoplastic or spect, the most striking evidence that malfunction of a pivotal benign conditions need to be ruled out with differential enzyme involved in miRNA processing has direct implications diagnosis. These conditions encompass abdominal cystic in tumor development in children is portrayed by the DICER1 lymphangiomas [12], benign liver lesions (infantile hepat- genetic syndrome, an autosomal dominant inherited condition ic hemangioendothelioma, mesenchymal hamartoma of that leads to abnormal endonuclease activity [24–26]. the liver, nodular regenerative hyperplasia, and focal nod- Described abdominal masses on DICER1-mutated children in- ular hyperplasia [13]), and congenital hydronephrosis clude cystic nephroma, Wilms tumor, and ovary cancer (partic- [14]. Among the most common ATs in children are ularly Sertoli-Leydig cell tumors) [26]. nephroblastoma (Wilms tumor), neuroblastoma, In the following sections, we present up-to-date informa- hepatoblastoma, germ-cell tumors, and rhabdomyosarco- tion about the altered miRNAs and their interplay with most ma [11]. Contrary to what is observed for the adult pop- common abdominal cancers in children: neuroblastoma, ulation, ATs in children exhibit embryonal histologies, nephroblastoma, hepatoblastoma, hepatocarcinoma, and adre- with direct implications on the neoplastic cell-of-origin, nal tumors. mechanisms related to tumorigenesis, and the therapeutic response of these lesions. 2.1 Neuroblastoma The evaluation of a child with an abdominal mass involves a number of diagnostic considerations on physical examina- Neuroblastoma (NB) is one of the most common solid tumors tion, including age and sex of the patient, the location of the in children. It originates from precursor cells of the parasym- mass, and the presence/absence of other related signs and pathetic nervous system and accounts for 15% of cancer- symptoms [15]. Diagnostic imaging (through magnetic reso- related deaths during childhood. NBs have a heterogeneous nance imaging, computed tomography, and/or ultrasound clinical presentation and course, ranging from spontaneous techniques) and the determination of the organ or tissue of regression to evolution into aggressive phenotypes and subse- origin can provide sufficient information for a diagnosis. quent death. Chromosomal alterations are common in this Most importantly, molecular approaches have greatly im- pathology, including loss of 3p, 11q, and 14q and gain of proved the understanding of the distinctive pathology of each 17q. Non-favorable forms of NB characteristically exhibit am- tumor type and the characterization of novel biomarkers, plification of MYCN (MNA) and are associated with the loss thereby creating new opportunities for therapy refinement to of 1p and gain of 17p [27, 28]. maximize cure and reduce therapy-associated toxicities. MiRNA dysregulation plays an important role in the etiol- In this regard, miRNAs have emerged as valuable tools for ogy of NB (Table 1). The first miRNA described as dysregu- early cancer detection and follow-up. These short non-coding lated in this tumor was miR-34a located at 1p36.23 [29–31]. RNAs have many clinical and therapeutic implications, main- In vitro reintroduction of miR-34a reduced cell proliferation ly due to their stability and specificity which enables their use and induced apoptosis with cell cycle arrest in cell lines car- as diagnostic markers, for surveillance of tumor progression rying a 1p36
Load more

Recommended publications
  • Adenomatoid Tumor of the Skin: Differential Diagnosis of an Umbilical Erythematous Plaque
    Title: Adenomatoid tumor of the skin: differential diagnosis of an umbilical erythematous plaque Keywords: Adenomatoid tumor, skin, umbilicus Short title: Adenomatoid tumor of the skin Authors: Ingrid Ferreira1, Olivier De Lathouwer2, Hugues Fierens3, Anne Theunis1, Josette André1, Nicolas de Saint Aubain3 1Dermatopathology laboratory, Department of Dermatology, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium. 2Department of Plastic surgery, Centre Hospitalier Interrégional Edith Cavell, Waterloo, Belgium. 3Department of Dermatology, Saint-Jean Hospital, Brussels, Belgium. 4Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Acknowledgements: None Corresponding author: Ingrid Ferreira This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/cup.13872 This article is protected by copyright. All rights reserved. Abstract Adenomatoid tumors are benign tumors of mesothelial origin that are usually encountered in the genital tract. Although they have been observed in other organs, the skin appears to be a very rare location with only one case reported in the literature to our knowledge. We report a second case of an adenomatoid tumor, arising in the umbilicus of a 44-year-old woman. The patient presented with an 8 months old erythematous and firm plaque under the umbilicus. A skin biopsy showed numerous microcystic spaces dissecting a fibrous stroma and being lined by flattened to cuboidal cells with focal intraluminal papillary formation. This poorly known diagnosis constitutes a diagnostic pitfall for dermatopathologists and dermatologists, and could be misdiagnosed as other benign or malignant entities.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Gene Standard Deviation MTOR 0.12553731 PRPF38A
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Gut Gene Standard Deviation MTOR 0.12553731 PRPF38A 0.141472605 EIF2B4 0.154700091 DDX50 0.156333027 SMC3 0.161420017 NFAT5 0.166316903 MAP2K1 0.166585267 KDM1A 0.16904912 RPS6KB1 0.170330192 FCF1 0.170391706 MAP3K7 0.170660513 EIF4E2 0.171572093 TCEB1 0.175363093 CNOT10 0.178975095 SMAD1 0.179164705 NAA15 0.179904998 SETD2 0.180182498 HDAC3 0.183971158 AMMECR1L 0.184195031 CHD4 0.186678211 SF3A3 0.186697697 CNOT4 0.189434633 MTMR14 0.189734199 SMAD4 0.192451524 TLK2 0.192702667 DLG1 0.19336621 COG7 0.193422331 SP1 0.194364189 PPP3R1 0.196430217 ERBB2IP 0.201473001 RAF1 0.206887192 CUL1 0.207514271 VEZF1 0.207579584 SMAD3 0.208159809 TFDP1 0.208834504 VAV2 0.210269344 ADAM17 0.210687138 SMURF2 0.211437666 MRPS5 0.212428684 TMUB2 0.212560675 SRPK2 0.216217428 MAP2K4 0.216345366 VHL 0.219735582 SMURF1 0.221242495 PLCG1 0.221688351 EP300 0.221792349 Sundar R, et al. Gut 2020;0:1–10. doi: 10.1136/gutjnl-2020-320805 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Gut MGAT5 0.222050228 CDC42 0.2230598 DICER1 0.225358787 RBX1 0.228272533 ZFYVE16 0.22831803 PTEN 0.228595789 PDCD10 0.228799406 NF2 0.23091035 TP53 0.232683696 RB1 0.232729172 TCF20 0.2346075 PPP2CB 0.235117302 AGK 0.235416298
    [Show full text]
  • Concurrent Hepatic Adenomatoid Tumor and Hepatic Hemangioma: a Case Report
    pISSN 2287-2728 eISSN 2287-285X Case Report http://dx.doi.org/10.3350/cmh.2012.18.2.229 Clinical and Molecular Hepatology 2012;18:229-234 Concurrent hepatic adenomatoid tumor and hepatic hemangioma: a case report Ji-Beom Kim1, Eunsil Yu2, Ju-Hyun Shim1, Gi-Won Song3, Gwang Un Kim1, Young-Joo Jin1, and Ho-Seop Park2 1Department of Internal Medicine, 2Department of Pathology, and 3Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea A 45-year-old male with alleged asymptomatic hepatic hemangioma of 4 years duration had right upper-quadrant pain and was referred to a tertiary hospital. Computed tomography and magnetic resonance imaging scans revealed a hypervascular mass of about 7 cm containing intratumoral multilobulated cysts. A preoperative liver biopsy was performed, but this failed to provide a definitive diagnosis. The patient underwent a partial hepatectomy of segments IV and VIII. The histologic findings revealed multifocal proliferation of flattened or cuboidal epithelioid cells and a highly vascular edematous stroma. Immunohistochemistry findings demonstrated that the epithelioid tumor cells were positive for cytokeratin (AE1/AE3), vimentin, calretinin, and cytokeratin 5/6, and were focally positive for CD10, and negative for WT1 and CD34, all of which support their mesothelial origin. Immunohistochemistry for a mesothelial marker should be performed for determining the presence of an adenomatoid tumor when benign epithelioid
    [Show full text]
  • Adenomatoid Tumour of the Adrenal Gland: a Case Report and Literature Review
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Jagiellonian Univeristy Repository POL J PATHOL 2010; 2: 97–102 ADENOMATOID TUMOUR OF THE ADRENAL GLAND: A CASE REPORT AND LITERATURE REVIEW MAGDALENA BIAŁAS1, WOJCIECH SZCZEPAŃSKI1, JOANNA SZPOR1, KRZYSZTOF OKOŃ1, MARTA KOSTECKA-MATYJA2, ALICJA HUBALEWSKA-DYDEJCZYK2, ROMANA TOMASZEWSKA1 1Chair and Department of Pathomorphology, Jagiellonian University Medical College, Kraków 2Chair and Department of Endocrinology, Jagiellonian University Medical College, Kraków Adenomatoid tumour (AT) is a rare, benign neoplasm of mesothelial origin, which usually occurs in the genital tract of both sexes. Occasionally these tumours are found in extra genital locations such as heart, pancreas, skin, pleura, omentum, lymph nodes, retroperitoneum, intestinal mesentery and adrenal gland. Histologically ATs show a mixture of solid and cystic patterns usually with focal presence of signet-ring like cells and scattered lymphoid infiltration. The most important thing about these tumours is not to misdiagnose them as primary malignant or metastatic neoplasms. We present a case of an adrenal AT in a 29-year-old asymptomatic male. The tumour was an incidental finding during abdominal CT-scan for an unrelated condition. We also present a review of the literature concerning adrenal gland AT and give possible differential diagnosis. Key words: adenomatoid tumour, adrenal gland, immunophenotype. Introduction histopathological examination. Additional sections were made for immunohistochemical analysis (for Adenomatoid tumour (AT) is a benign neoplasm details see Table I). of mesothelial origin [1-3]. The usual place of its Proliferative activity of the tumour was deter- appearance is the male and female genital tract, most mined using immunohistochemical staining for often epididymis in men and fallopian tube in women nuclear protein MIB-1 (Ki-67).
    [Show full text]
  • Adenomatoid Tumor of the Pancreas
    Adenomatoid Tumor of the Pancreas: A Case Report with Comparison of Histology and Aspiration Cytology Kerith Overstreet, M.D., Chris Wixom, M.D., Ahmed Shabaik, M.D., Michael Bouvet, M.D., Brian Herndier, M.D., Ph.D. Departments of Pathology (KO, CW, AS, BH) and Surgery (MB), University of California, San Diego Medical Center, San Diego, California ovarian hilum (2). Sporadic case reports have also We present a 58-year-old woman who presented noted adenomatoid tumors in such varied ex- with a 1.5-cm, hypodense lesion in the head of the tragenital locations as the adrenal gland (4, 5), small pancreas. Endoscopic ultrasound-guided fine- intestines, omentum, retroperitoneum, bladder, needle aspiration yielded bland, monotonous cells and pleura (3–5). To date, both ultrastructural and with wispy cytoplasm, slightly granular chromatin, immunohistochemical evidence have demon- and small nucleoli. A presumptive diagnosis of a strated this tumor’s mesothelial origin (2, 3, 5). In neuroendocrine lesion was rendered. Whipple pro- this context, we present an adenomatoid tumor of cedure yielded a well-circumscribed, encapsulated the pancreas. To our knowledge, this is the first lesion with dense, hyalinized stroma and a periph- reported case in this location. Herein we report eral rim of lymphocytes. Spindled and epithelioid both cytological and histochemical results docu- cells formed short tubules, cords, and nests. The menting this benign neoplasm in an unusual neoplasm stained for CK 5/6, calretinin, vimentin, location. CD 99, pancytokeratin, and EMA, consistent with mesothelial origin. This characteristic histology and immunohistochemistry is consistent with an ad- CASE REPORT enomatoid tumor. We believe we are the first to A 58-year-old woman with a history of hyperten- report this benign neoplasm in such an unusual sion, cholecystitis, and arthritis presented with a location.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • ZNF346 Antibody (Pab)
    21.10.2014ZNF346 antibody (pAb) Rabbit Anti -Human/Mouse/Rat Zinc finger protein 346 (JAZ) Instruction Manual Catalog Number PK-AB718-6003 Synonyms ZNF346 Antibody: Zinc finger protein 346, Just another zinc finger protein, JAZ Description ZNF346, also known as JAZ (just another zinc-finger protein), is a nucleolar, zinc finger protein which preferentially binds to double-stranded (ds) RNA or RNA/DNA hybrids with high affinity via C2H2 zinc fingers. ZNF346 contains four CH-type zinc finger motifs that are connected by long (28-38) amino acid linker sequences. ZNF346 is expressed in all tissues tested and localizes to the nucleus, primarily the nucleolus. ZNF346 is exported by exportin-5 but translocates back into nuclei by a facilitated diffusion mechanism. ZNF346 interacts with ILF3 in an RNA-independent manner and may be involved in cell growth and survival. Quantity 100 µg Source / Host Rabbit Immunogen ZNF346 antibody was raised against a 20 amino acid synthetic peptide near the amino terminus of human ZNF346. Purification Method Affinity chromatography purified via peptide column. Clone / IgG Subtype Polyclonal antibody Species Reactivity Human, Mouse, Rat Specificity Formulation Antibody is supplied in PBS containing 0.02% sodium azide. Reconstitution During shipment, small volumes of antibody will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. Storage & Stability Antibody can be stored at 4ºC for three months and at -20°C for up to one year.
    [Show full text]
  • Host Cell Factors Necessary for Influenza a Infection: Meta-Analysis of Genome Wide Studies
    Host Cell Factors Necessary for Influenza A Infection: Meta-Analysis of Genome Wide Studies Juliana S. Capitanio and Richard W. Wozniak Department of Cell Biology, Faculty of Medicine and Dentistry, University of Alberta Abstract: The Influenza A virus belongs to the Orthomyxoviridae family. Influenza virus infection occurs yearly in all countries of the world. It usually kills between 250,000 and 500,000 people and causes severe illness in millions more. Over the last century alone we have seen 3 global influenza pandemics. The great human and financial cost of this disease has made it the second most studied virus today, behind HIV. Recently, several genome-wide RNA interference studies have focused on identifying host molecules that participate in Influen- za infection. We used nine of these studies for this meta-analysis. Even though the overlap among genes identified in multiple screens was small, network analysis indicates that similar protein complexes and biological functions of the host were present. As a result, several host gene complexes important for the Influenza virus life cycle were identified. The biological function and the relevance of each identified protein complex in the Influenza virus life cycle is further detailed in this paper. Background and PA bound to the viral genome via nucleoprotein (NP). The viral core is enveloped by a lipid membrane derived from Influenza virus the host cell. The viral protein M1 underlies the membrane and anchors NEP/NS2. Hemagglutinin (HA), neuraminidase Viruses are the simplest life form on earth. They parasite host (NA), and M2 proteins are inserted into the envelope, facing organisms and subvert the host cellular machinery for differ- the viral exterior.
    [Show full text]
  • Temporal Endogenous Gene Expression Profiles in Response to Polymer-Mediated Transfection and Profile Comparison to Lipid-Mediated Transfection Timothy M
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Biological Systems Engineering: Papers and Biological Systems Engineering Publications 2015 Temporal endogenous gene expression profiles in response to polymer-mediated transfection and profile comparison to lipid-mediated transfection Timothy M. Martin University of Nebraska Medical Center, [email protected] Sarah A. Plautz University of Nebraska-Lincoln, [email protected] Angela K. Pannier University of Nebraska-Lincoln, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/biosysengfacpub Part of the Bioresource and Agricultural Engineering Commons, Environmental Engineering Commons, and the Other Civil and Environmental Engineering Commons Martin, Timothy M.; Plautz, Sarah A.; and Pannier, Angela K., "Temporal endogenous gene expression profiles in response to polymer-mediated transfection and profile comparison to lipid-mediated transfection" (2015). Biological Systems Engineering: Papers and Publications. 518. https://digitalcommons.unl.edu/biosysengfacpub/518 This Article is brought to you for free and open access by the Biological Systems Engineering at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Biological Systems Engineering: Papers and Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Published in The Journal of Gene Medicine 17 (2015), pp. 33–53. doi 10.1002/jgm.2822 PMID: 25663627 Copyright © 2015 John Wiley & Sons, Ltd. Used by permission Submitted 17 November 2014; revised 1 February 2015; accepted 3 February 2015 digitalcommons.unl.edu Temporal endogenous gene expression profiles in response to polymer-mediated transfection and profile comparison to lipid-mediated transfection Timothy M. Martin,1 Sarah A. Plautz,2 and Angela K.
    [Show full text]
  • Unusual Cases in Genitourinary Pathology
    Unusual and Challenging Cases in Genitourinary Pathology Daniel Albertson MD Associate Professor University of Utah Department of Anatomic Pathology I have no conflict(s) of interest to disclose Case #1: 26 year old male with rapidly growing left paratesticular mass measuring 3.5 cm Gross Examination: 3.5 cm round firm mass with yellow center MORPHOLOGY AND IHC PROFILE • Well Circumscribed and Non Encapsulated • Minimal Invasion Into Surrounding Tissue • Peripheral Lymphoid Aggregates • Nests and Cords • Round Nuclei and Abundant Pink Cytoplasm • Central Necrosis . WT-1 + . CK7 + . CK5 + . CK20, HMB-45, GATA-3, SMA, INHIBIN – DIAGNOSIS: INFARCTED ADENOMATOID TUMOR Differential Diagnosis: • Mesothelioma • Typically a gross papillary appearance with tumor studding of tunica • Microscopically infiltrative border and lack of circumscription and typically lacks adenomatoid-like vacuoles • Mitoses more common • Leiomyoma/Leiomyosarcoma • Vascular Lesions (Epithelioid Hemangioendothelioma/Angiosarcoma) • Sex Cord Stromal Tumors • Adenocarcinoma • Epididymitis Skinnider, B. F. and R. H. Young (2004). Infarcted adenomatoid tumor: a report of five cases of a facet of a benign neoplasm that may cause diagnostic difficulty. Am J Surg Pathol 28(1): 77-83. CASE #2: 46 YEAR OLD MALE WITH LONGSTANDING HISTORY OF RIGHT TESTICULAR GROWTH IMAGING FINDINGS: SCROTAL ULTRASOUND DEMONSTRATED A 4 X 2.4 CM HETEROGENOUS HYPERECHOIC MASS ARISING FROM THE RIGHT POSTERIOR-INFERIOR SCROTAL WALL. CD34 MORPHOLOGY AND IHC PROFILE • Somewhat delineated lesion with bland spindle cells, mature adipocytes, and occasional uni- and mutivacuolated lipoblasts • Collagenous to myxoid extracellular matrix • Mild cytologic atypia with nuclear hyperchromasia • No obvious mitoses • No necrosis • CD34 (+) • CD10, DESMIN, SMA (-) • Negative for MDM2 Amplification (NORMAL) • MDM2/CEP12 Ratio: 1.0 • Average MDM2 Signal Number per Cell: 1.8 DIAGNOSIS: ATYPICAL SPINDLE CELL LIPOMATOUS NEOPLASM Clincial Behavior: Most cured by surgery but 10-15% may recur locally.
    [Show full text]
  • Testicular and Paratesticular Tumors Study Questions Sarah M
    Testicular and Paratesticular Tumors Study Questions Sarah M. Kelting, M.D.; Stacey E. Mills, M.D These questions correspond to the glass slide study set available in the Anatomic Pathology resident library. While photomicrographs are provided here with each question, we strongly recommend review of the glass slides in order to fully benefit from each case. Thank you to Jacob S. Grange, M.D. for his contribution of many of the accompanying photomicrographs. 1. S13-1687 A 40-year-old man presents with a testicular mass. What is the expected immunohistochemical profile of this lesion? A. SALL4 +, PLAP +, OCT3/4 +, CD117 -, CD30 +, AE1/AE3 + B. SALL4 +, PLAP +, OCT3/4 +, CD117 +, CD30 - C. SALL4 -, PLAP -, OCT3/4 -, CD117 -, CD30 -, inhibin + D. SALL4 +, PLAP +, OCT3/4 -, CD117 -, CD30-, AFP +, AE1/AE3 + E. SALL4 -, PLAP -, OCT3/4 -, CD117 -, CD30+, EMA + 2. CO16-2576 An 84-year-old man presents with a 4 cm testicular mass. On histologic examination, your differential diagnosis includes seminoma and spermatocytic tumor. In considering the differences between these two tumors, which feature would favor that this represents spermatocytic tumor? A. Negative staining for CD117 B. Presence of intratubular germ cell neoplasia (IGCN) C. Prominent associated granuloma formation D. Presence of three cell types E. Positive staining for OCT3/4 3. S05-28333 This is a testicular tumor from a 28-year-old man. Histologic examination demonstrates a mixed germ cell tumor (GCT). Adjacent to the primary tumor, the presumptive precursor lesion is seen (photomicrograph). Which of the following statements about testicular GCT precursor lesions is false? A. Most adult germ cell tumors are thought to be derived from intratubular germ cell neoplasia, unclassified type (IGCNU), the invasive derivative of which appears to be seminoma.
    [Show full text]